Parameswara Rao Vuddanda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Parameswara Rao Vuddanda has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Sanjay Singh
Department of Pharmaceutical Sciences, School of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University (A Central University), Vidya Vihar, Raebareli Road, Lucknow 226025, India
10 shared publications - Sitaram P. Velaga
Pharmaceutical and Biomaterial Research Group, Division of Medical Sciences, Department of Health Sciences, Luleå University of Technology, Luleå 97187, Sweden
9 shared publications Sanjay Singh
6 shared publicationsAchint Jain
Pharma Research, Lupin Limited (Research Park), Pune-411042, India
4 shared publications- Javier Octavio Morales
Departamento de Ciencias y Tecnología Farmacéutica, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Santiago 8380494, Chile
3 shared publications - Amit Mishra
Maharana Pratap College of Pharmaceutical Sciences, Kanpur, India
2 shared publications
Latest Publications
- 1 October 2019
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 53, 101122
Silodosin oral films: Development, physico-mechanical properties and in vitro dissolution studies in simulated saliva
- 1 October 2019
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 53, 101122
Silodosin oral films: Development, physico-mechanical properties and in vitro dissolution studies in simulated saliva
- Open Access
- 1 October 2018
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 549 (1-2) , 363-369
Printing T3 and T4 oral drug combinations as a novel strategy for hypothyroidism
- 1 October 2018
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 549 (1-2) , 363-369
Open AccessPrinting T3 and T4 oral drug combinations as a novel strategy for hypothyroidism
- 22 June 2018
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 19 (8) , 3376-3387
The Effect of Inkjet Printing over Polymeric Films as Potential Buccal Biologics Delivery Systems
The buccal mucosa appears as a promissory route for biologic drug administration, and pharmaceutical films are flexible dosage forms that can be used in the buccal mucosa as drug delivery systems for...
- 22 June 2018
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 19 (8) , 3376-3387
The Effect of Inkjet Printing over Polymeric Films as Potential Buccal Biologics Delivery Systems
The buccal mucosa appears as a promissory route for biologic drug administration, and pharmaceutical films are flexible dosage forms that can be used in the buccal mucosa as drug delivery systems for...
- 1 May 2018
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 117, 80-87
Personalisation of warfarin therapy using thermal ink-jet printing
- 1 May 2018
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 117, 80-87
Personalisation of warfarin therapy using thermal ink-jet printing
- 1 November 2017
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 109, 372-380
Effect of surfactants and drug load on physico-mechanical and dissolution properties of nanocrystalline tadalafil-loaded oral films
- 1 November 2017
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 109, 372-380
Effect of surfactants and drug load on physico-mechanical and dissolution properties of nanocrystalline tadalafil-loaded oral films
- Open Access
- 31 July 2017
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 19 (1) , 425-435
Experimental Studies and Modeling of the Drying Kinetics of Multicomponent Polymer Films
The process of drying thin polymer films is an important operation that influences the film structure and solid state, and the stability of the product. Th
- 31 July 2017
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 19 (1) , 425-435
Open AccessExperimental Studies and Modeling of the Drying Kinetics of Multicomponent Polymer Films
The process of drying thin polymer films is an important operation that influences the film structure and solid state, and the stability of the product. Th
- 1 January 2017
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 96, 290-298
Effect of plasticizers on the physico-mechanical properties of pullulan based pharmaceutical oral films
- 1 January 2017
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 96, 290-298
Effect of plasticizers on the physico-mechanical properties of pullulan based pharmaceutical oral films
- 1 December 2016
- Published by Elsevier in Journal of Herbal Medicine
- Vol. 6 (4) , 163-170
Boswellic acid – Medicinal use of an ancient herbal remedy
- 1 December 2016
- Published by Elsevier in Journal of Herbal Medicine
- Vol. 6 (4) , 163-170
Boswellic acid – Medicinal use of an ancient herbal remedy
- 5 May 2016
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 6 (55) , 50336-50348
Intravenous administration of trans-resveratrol-loaded TPGS-coated solid lipid nanoparticles for prolonged systemic circulation, passive brain targeting and improved in vitro cytotoxicity against C6 glioma cell lines
trans-Resveratrol (RSV), a natural molecule isolated from red wine, is widely known for several therapeutic potentials. RSV is proved for cardioprotective, vasodilation, anti-inflammatory, and anticancer effects. Recently, anticancer potential against glioma cells has also been reported. However, the clinical application of RSV in glioma treatment is largely limited because of its rapid metabolism and elimination from systemic circulation thereby exhibiting low biological half-life and poor brain distribution as well. Therefore, the main objective of this study was to enhance the circulation time, biological half-life and passive brain targeting of RSV using D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS)-coated solid lipid nanoparticles (RSV-TPGS-SLN). RSV-TPGS-SLN formulations were prepared by a solvent emulsification evaporation method and evaluated for several nanoparticulate characteristics. In vitro anticancer potential and cellular internalization of nanoparticles were also investigated in C6 glioma cell lines. Pharmacokinetics and biodistribution studies were carried out following intravenous administration in healthy Charles Foster rats. RSV-TPGS-SLN showed significantly higher in vitro cytotoxicity against C6 glioma cell lines and excellent cellular internalization. RSV-TPGS-SLN showed 11.12 and 9.37 times higher area under the curve and plasma half-life than RSV solution, respectively. Moreover, brain distribution of RSV-TPGS-SLN was found to be 9.23 times higher in comparison to that of RSV alone. Thus, we anticipate that the RSV-TPGS-SLN formulation can be applied as a potential tool for improving circulation time, biological half-life and passive brain targeting of RSV, thereby being immensely useful in the treatment of glioma.
- 5 May 2016
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 6 (55) , 50336-50348
Intravenous administration of trans-resveratrol-loaded TPGS-coated solid lipid nanoparticles for prolonged systemic circulation, passive brain targeting and improved in vitro cytotoxicity against C6 glioma cell lines
trans-Resveratrol (RSV), a natural molecule isolated from red wine, is widely known for several therapeutic potentials. RSV is proved for cardioprotective, vasodilation, anti-inflammatory, and anticancer effects. Recently, anticancer potential against glioma cells has also been reported. However, the clinical application of RSV in glioma treatment is largely limited because of its rapid metabolism and elimination from systemic circulation thereby exhibiting low biological half-life and poor brain distribution as well. Therefore, the main objective of this study was to enhance the circulation time, biological half-life and passive brain targeting of RSV using D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS)-coated solid lipid nanoparticles (RSV-TPGS-SLN). RSV-TPGS-SLN formulations were prepared by a solvent emulsification evaporation method and evaluated for several nanoparticulate characteristics. In vitro anticancer potential and cellular internalization of nanoparticles were also investigated in C6 glioma cell lines. Pharmacokinetics and biodistribution studies were carried out following intravenous administration in healthy Charles Foster rats. RSV-TPGS-SLN showed significantly higher in vitro cytotoxicity against C6 glioma cell lines and excellent cellular internalization. RSV-TPGS-SLN showed 11.12 and 9.37 times higher area under the curve and plasma half-life than RSV solution, respectively. Moreover, brain distribution of RSV-TPGS-SLN was found to be 9.23 times higher in comparison to that of RSV alone. Thus, we anticipate that the RSV-TPGS-SLN formulation can be applied as a potential tool for improving circulation time, biological half-life and passive brain targeting of RSV, thereby being immensely useful in the treatment of glioma.